Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12

被引:176
作者
Yao, L
Sgadari, C
Furuke, K
Bloom, ET
Teruya-Feldstein, J
Tosato, G
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Hematol Prod, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, Hematopathol Sect, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V93.5.1612.405a13_1612_1621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-12 (IL-12) inhibits angiogenesis in vivo by inducing interferon-gamma (IFN-gamma) and other downstream mediators. Here, we report that neutralization of natural killer (NK) cell function with antibodies to either asialo GM1 or NK 1.1 reversed IL-12 inhibition of basic fibroblast growth factor (bFGF)-induced angiogenesis in athymic mice. By immunohistochemistry, those sites where bFGF-induced neovascularization was inhibited by IL-12 displayed accumulation of NK cells and the presence of IP-10-positive cells. Based on expression of the cytolytic mediators perforin and granzyme B, the NK cells were locally activated. Experimental Burkitt lymphomas treated locally with IL-12 displayed tumor tissue necrosis, vascular damage, and NK-cell infiltration surrounding small vessels. After activation in vitro with IL-12 NK cells from nude mice became strongly cytotoxic for primary cultures of syngeneic aortic endothelial cells. Cytotoxicity was neutralized by antibodies to IFN-gamma. These results document that NK cells are required mediators of angiogenesis inhibition by IL-12 and provide evidence that NK-cell cytotoxicity of endothelial cells is a potential mechanism by which IL-12 can suppress neovascularization.
引用
收藏
页码:1612 / 1621
页数:10
相关论文
共 53 条
[1]   MOLECULES AND STRUCTURES INVOLVED IN THE ADHESION OF NATURAL-KILLER-CELLS TO VASCULAR ENDOTHELIUM [J].
ALLAVENA, P ;
PAGANIN, C ;
MARTINPADURA, I ;
PERI, G ;
GABOLI, M ;
DEJANA, E ;
MARCHISIO, PC ;
MANTOVANI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02) :439-448
[2]   HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO [J].
ANGIOLILLO, AL ;
SGADARI, C ;
TAUB, DD ;
LIAO, F ;
FARBER, JM ;
MAHESHWARI, S ;
KLEINMAN, HK ;
REAMAN, GH ;
TOSATO, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :155-162
[3]   Interleukin-15 promotes angiogenesis in vivo [J].
Angiolillo, AL ;
Kanegane, H ;
Sgadari, C ;
Reaman, GH ;
Tosato, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (01) :231-237
[4]  
BALLAS ZK, 1993, J IMMUNOL, V150, P17
[5]  
BARIOZZARI T, 1985, J IMMUNOL, V134, P2783
[6]  
Borgstrom P, 1996, CANCER RES, V56, P4032
[7]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[8]   ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS [J].
BRUNDA, MJ ;
LUISTRO, L ;
WARRIER, RR ;
WRIGHT, RB ;
HUBBARD, BR ;
MURPHY, M ;
WOLF, SF ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1223-1230
[9]  
DAMLE NK, 1987, J IMMUNOL, V138, P1779
[10]  
DAMLE NK, 1989, J IMMUNOL, V142, P2660